UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.343

Sortiert nach

Healthcare providers as sources of vaccine-preventable diseases

Vaccine, 2014-08, Vol.32 (38), p.4814-4822

2014

Link zum Volltext

Verfügbarkeit prüfen

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?

Vaccine, 2017-08, Vol.35 (35), p.4470-4474

2017

Link zum Volltext

Verfügbarkeit prüfen

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

Vaccine, 2012-11, Vol.30 (5), p.F123-F138

2012

Link zum Volltext

Verfügbarkeit prüfen

Flaviviruses and flavivirus vaccines

Vaccine, 2012-06, Vol.30 (29), p.4301-4306

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

Vaccine, 2015-05, Vol.33 (23), p.2684-2689

2015

Link zum Volltext

Verfügbarkeit prüfen

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

Vaccine, 2014-03, Vol.32 (12), p.1326-1337

2014

Link zum Volltext

Verfügbarkeit prüfen

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps

Vaccine, 2016-06, Vol.34 (26), p.2939-2947

2016

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors

Vaccine, 2009-06, Vol.27 (30), p.3935-3944

2009

Link zum Volltext

Verfügbarkeit prüfen

Meningococcal disease: Clinical presentation and sequelae

Vaccine, 2012-05, Vol.30, p.B3-B9

2012

Link zum Volltext

Verfügbarkeit prüfen

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

Vaccine, 2012-09, Vol.30 (42), p.6016-6019

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2

Vaccine, 2008-06, Vol.26 (27), p.3443-3451

2008

Link zum Volltext

Verfügbarkeit prüfen

The principles and feasibility of disease eradication

Vaccine, 2011-12, Vol.29 (S4), p.D70-D73

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation – A systematic review of randomized trials, observational studies and case reports

Vaccine, 2017-03, Vol.35 (9), p.1216-1226

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine

Vaccine, 2017-02, Vol.35 (7), p.1046-1054

2017

Link zum Volltext

Verfügbarkeit prüfen

The changing and dynamic epidemiology of meningococcal disease

Vaccine, 2012-05, Vol.30, p.B26-B36

2012

Link zum Volltext

Verfügbarkeit prüfen

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

Vaccine, 2013-08, Vol.31, p.D52-D57

2013

Link zum Volltext

Verfügbarkeit prüfen

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine

Vaccine, 2013-08, Vol.31, p.D20-D26

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccination policies for healthcare workers in Europe

Vaccine, 2014-08, Vol.32 (38), p.4876-4880

2014

Link zum Volltext

Verfügbarkeit prüfen

Burden of vaccine preventable diseases at large events

Vaccine, 2015-11, Vol.33 (48), p.6552-6563

2015

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with proteins involved in tick–pathogen interactions reduces vector infestations and pathogen infection

Vaccine, 2013-12, Vol.31 (49), p.5889-5896

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccine impact: Benefits for human health

Vaccine, 2016-12, Vol.34 (52), p.6707-6714

2016

Link zum Volltext

Verfügbarkeit prüfen

Status of vaccine research and development of vaccines for leishmaniasis

Vaccine, 2016-06, Vol.34 (26), p.2992-2995

2016

Link zum Volltext

Verfügbarkeit prüfen

Vaccinomics, the new road to tick vaccines

Vaccine, 2013-12, Vol.31 (50), p.5923-5929

2013

Link zum Volltext

Verfügbarkeit prüfen

The test-negative design for estimating influenza vaccine effectiveness

Vaccine, 2013-04, Vol.31 (17), p.2165-2168

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.343

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieVaccine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.340)
Mit Volltextzugriff
(7.343)

Publikationsform

Artikel
(7.343)

Sprache

Erscheinungsjahr

n.n

Thema

Allergy And Immunology
(7.230)
Immunology
(7.164)
Life Sciences & Biomedicine
(7.159)
Medicine, Research & Experimental
(7.159)
Research & Experimental Medicine
(7.159)
Science & Technology
(7.159)
Vaccines
(6.061)
Humans
(4.784)
Biological And Medical Sciences
(4.095)
Fundamental And Applied Biological Sciences. Psychology
(4.056)
Microbiology
(4.039)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(3.992)
Female
(3.926)
Applied Microbiology
(3.889)
Animals
(3.408)
Immunization
(2.659)
Miscellaneous
(2.386)
Male
(2.368)
Vaccination
(2.199)
Infectious Diseases
(1.772)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(7.343)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(7.340)
Elsevier ScienceDirect Journals Complete
(7.340)
EZB Free E-Journals
(3)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1)
Single Journals
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Archives Of Dermatology
(1)

Menü

Weitere Dienste

Einstellungen

Healthcare providers as sources of vaccine-preventable diseases

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

Flaviviruses and flavivirus vaccines

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors

Meningococcal disease: Clinical presentation and sequelae

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2

The principles and feasibility of disease eradication

Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation – A systematic review of randomized trials, observational studies and case reports

Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine

The changing and dynamic epidemiology of meningococcal disease

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine

Vaccination policies for healthcare workers in Europe

Burden of vaccine preventable diseases at large events

Vaccination with proteins involved in tick–pathogen interactions reduces vector infestations and pathogen infection

Vaccine impact: Benefits for human health

Status of vaccine research and development of vaccines for leishmaniasis

Vaccinomics, the new road to tick vaccines

The test-negative design for estimating influenza vaccine effectiveness

Aktive Filter

Suchergebnisse filtern